| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514400400 | Protozoa destroying or inhibiting | 12 |
| 20110021418 | ENRICHED HAPTOGLOBIN POLYMERS FOR THE TREATMENT OF DISEASE - Haptoglobin (Hp) removes cell-free Hemoglobin (Hb), with different physiological effects depending on the particular Hp polymer. We propose that material enriched for alpha 1 chain Hp polymeric forms, such as those made from Cohn fraction V precipitate, will be more suitable for the treatment of certain diseases benefiting from both an antioxidant and anti-inflammatory component, such as for hemolytic disease. Material enriched for alpha-2 chain Hp polymeric forms, made for example from Cohn fraction IV precipitate, will be more suitable for treatment of diseases where an angiogenic, and/or inflammatory affect, and/or limited extravasation is desirable. | 01-27-2011 |
| 20110046044 | Use of a cysteine protease of Plasmodium vivax - A use of vivapain-4 (VX-4), which is a cysteine protease of | 02-24-2011 |
| 20110105388 | NOVEL POSSIBILITY OF CONTROLLING GIARDIOSIS - The present invention relates to the use of nifurtimox for the treatment of giardiosis, in particular in dogs and cats. | 05-05-2011 |
| 20110257083 | MSP-1 PROTEIN PREPARATIONS FROM PLASMODIUM - The invention relates to a merozoite surface protein 1 (“MSP-1”) preparation | 10-20-2011 |
| 20120108502 | NOVEL ANTI-PARASITIC COMPOUNDS - A novel structural class of highly N-methylated linear lipopeptide compounds useful for the treatment of parasitic disease. | 05-03-2012 |
| 20120172292 | METHOD FOR PROTECTION OF ANTIMICROBIAL AND ANTICANCER DRUGS FROM INACTIVATION BY NITRIC OXIDE - This invention discloses a method for enhancing the efficacy of antimicrobial, anti-protozoa and anti-cancer treatments by co-administering an inhibitor of endogenous NO production and/or NO scavenger. | 07-05-2012 |
| 20120245082 | Novel Antimicrobial Activity of Chicken NK-2 Peptide Against Apicomplexan Protozoa - NK-2 synthetic peptide derived from cationic core region of porcine NK-lysin has an antimicrobial and antitumor polypeptide that is considered to play a pivotal role in innate defense immunity. To evaluate the antimicrobial properties of synthetic chicken NK-lysin peptides, we investigated cytolytic activity against apicomplexan parasites like | 09-27-2012 |
| 20120295844 | USE OF APROTININ FOR TREATING PARASITIC INFECTIONS AND PROGNOSING BOVINE TRYPANOTOLERANCE - The present invention relates the use of aprotinin in the treatment of parasitic diseases or infections that affect domesticated mammals, in particular the cattle, especially bovines. In particular, aprotinin finds application in the fight against pathogenic effects induced by parasites in the Trypanosomatidae family, such as the protozoa that belong to the | 11-22-2012 |
| 20130303439 | CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9 - The invention related to chimeric peptides including a penetrating peptide and a binding domain of PP2A catalytic subunit to caspase-9 which have pro-apoptotic activity. These chimeric peptides may be used for the treatment of hyperproliferative disorders. | 11-14-2013 |
| 20140221276 | FURTHER NOVEL ANTI-PARASITIC COMPOUNDS - A novel structural class of highly N-methylated linear lipopeptide compounds useful for the treatment of parasitic disease. | 08-07-2014 |
| 20160008419 | Methods and Compositions for the Prevention and Treatment of Parasitic Disease | 01-14-2016 |
| 20190144498 | PEPTIDES HAVING TETRAHEDRAL MIMICKING GROUPS AS INHIBITORS OF RHOMBOID PROTEASES | 05-16-2019 |
